Given that the synergistic effects of simvastatin plus lunasin on elevating the LDLR level and functionally enhancing LDL uptake were observed in HepG2 cells, we investigated the in vivo anti-hyperlipidemia activity of simvastatin combined with lunasin in ApoE−/− mice. Here, LDLR is linked to hyperlipidemia.